Vincent Law (@Binzento) header
Vincent Law (@Binzento) profile picture

@Vogue_Italia and @NotJustALabel contributor. Cancer Scientist published in @NeuroOnc. I eat 9 meals a day.

Tampa, FL
Joined September 2011
Photo by Vincent Law (@Binzento)Photo by Vincent Law (@Binzento)Photo by Vincent Law (@Binzento)Photo by Vincent Law (@Binzento)Photo by Vincent Law (@Binzento)Photo by Vincent Law (@Binzento)Photo by Vincent Law (@Binzento)Photo by Vincent Law (@Binzento)Photo by Vincent Law (@Binzento)
Can a new immunotherapy activate the immune system against breast cancer that has spread to the cerebrospinal fluid? At #SITC26 Vincent Law (@Binzento) shares findings from a first-in-human clinical trial showing adaptive immune responses and changes in the cerebrospinal fluid's immune environment. #MoffittSITC26
3
116
Pioneering change for patients starts with discovery. At #SITC26, connect with Moffitt’s immunotherapy experts and explore research advancing the next generation of cancer care. Visit booth #901 to meet our team! Plan your schedule with our full presentation list: moffitt.org/SITC #MoffittSITC26 @sitcancer
131
At #SNO2025, Vincent Law (@Binzento) shares a first-in-human trial of intrathecal cDC1 therapy for breast cancer leptomeningeal disease. Early results show safety and Th1-driven immune activation, with expanded T and B cells, reduced CSF tumor burden. Eighty-three percent of patients maintained or improved their performance status. #MoffittSNO2025
2
5
601
At #SNO2025, Vincent Law (@Binzento) presents preclinical data identifying homoharringtonine (HHT) as a potent candidate for melanoma leptomeningeal disease. HHT demonstrates strong cytotoxicity, crosses blood-brain and CSF barriers and in a murine model significantly extends survival with 27% complete responses. #MoffittSNO2025
3
4
568
our success in treating a breast cancer patient with leptomeningeal disease in a clinical trial at @MoffittNews is recently on @FOX13News Moffitt receives grant to study rare condition youtu.be/36G37PK-baQ?si=lzr0… via @YouTube #lmd #cancer #breastcancer #science
1
5
9
3,296
don’t spend too much time with your family tomorrow we still need you here to post ok?
1
187
good morning, i will continue to do my part to be a better human being.
162
Fantastic session on cellular immunotherapies at @EANOassociation 2024. Thank you for having me to share our latest research findings in intrathecal cDC1 therapy to treat breast cancer-LMD in preclinical models and phase 1 trial 🥺💪🧠 @MoffittNews. Also, #HappyBirthdayEANO
1
2
254
Vincent Law retweeted
Outstanding research results in a clear presentation: this is what characterises the poster prizes at our annual EANO conferences. Proud to highlight the winner of "Best Poster: Translational research" from #EANO2023: Vincent Law, Tampa, USA. #NeuroOncology #tumorbiology
1
3
573
#GBMDay is a day for the brain tumor community to raise nationwide awareness of #glioblastoma, and we appreciate the champions in Congress working to help us defeat this disease. @USRepKCastor @SenRickScott, join us by supporting the #GBM Awareness Day resolution!
1
167
#GBMDay is a day for the brain tumor community to raise nationwide awareness of #glioblastoma, and we appreciate the champions in Congress working to help us defeat this disease. @marcorubio, thank you for supporting the #GBM Awareness Day resolution!
144
Our Moffitt experts are ready for day 2 of #ASCO24! #MoffittASCO24
Excited for the AI and CNS presentations today at #ASCO @ASCO 2024. #cancer #clinicaloncology
3
8
1,772
moving the needle forward for leptomeningeal disease TNBC @Binzento IT dendritic cell vaccine for BC LMD #ASCO24
2
4
421
At #ASCO24, Vincent Law (@Binzento) joined us to discuss the use of IT cDC1 vaccine as a treatment for breast cancer-associated leptomeningeal disease. #MoffittASCO24 Read more: bit.ly/3ywzAjh @ASCO
1
5
10
1,091
Excited for the AI and CNS presentations today at #ASCO @ASCO 2024. #cancer #clinicaloncology
1
5
2,060
Join Vincent Law (@Binzento), tomorrow at #ASCO24 for a discussion on the development of therapeutics for melanoma-associated LMD. ⏰: 6/1 from 9:00 a.m. -12:00 p.m. CDT 📍: Hall A - 2032 Board 331 Learn more ➡️ bit.ly/3V4j7dI #MoffittASCO24 @ASCO
4
9
679